Simplex Trading’s Alto Neuroscience ANRO Stock Holding History

Simplex Trading’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-450	Closed	-$10.4K	–	10489
2026 Q1	$10.1K	Buy	+450	New	+$8.34K	﹤0.01%	7351
2025 Q2	–	Sell	-584	Closed	-$1.39K	–	9918
2025 Q1	$1K	Buy	+584	New	+$2.09K	﹤0.01%	8342

Other funds holding ANRO

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSC

Spruce Street Capital New York $510M AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Simplex Trading's ANRO Position: Q2 2026 in Review

Simplex Trading sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 450 shares — an estimated $10.4K sold.

Simplex Trading first reported a position in ANRO in Q1 2025 and held it in 2 quarters. The position peaked at $10.1K in Q1 2026. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

Simplex Trading reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 450 Alto Neuroscience shares in Q2 2026, an estimated $10.4K.
Simplex Trading first reported a position in Alto Neuroscience in Q1 2025 and held it in 2 quarters.
Simplex Trading's Alto Neuroscience position peaked at $10.1K in Q1 2026.
114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.